| 产品编号 | CFN60069 | |
| CAS编号 | 1009119-64-5 | |
| 分子式 = 分子量 | C40H50N8O6 = 738.88 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 1mg | QQ客服:2056216494 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 5mg | QQ客服:2056216494 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 10mg | QQ客服:2056216494 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 20mg | QQ客服:2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Daclatasvir (BMS-790052, EBP883) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. | |||
| Targets: | HCV NS5A | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3534 mL | 6.767 mL | 13.534 mL | 27.068 mL | 33.835 mL |
| 5 mM | 0.2707 mL | 1.3534 mL | 2.7068 mL | 5.4136 mL | 6.767 mL |
| 10 mM | 0.1353 mL | 0.6767 mL | 1.3534 mL | 2.7068 mL | 3.3835 mL |
| 50 mM | 0.0271 mL | 0.1353 mL | 0.2707 mL | 0.5414 mL | 0.6767 mL |
| 100 mM | 0.0135 mL | 0.0677 mL | 0.1353 mL | 0.2707 mL | 0.3383 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 丁酸异戊酯; Isoamyl butyrate | CFN70014 | 106-27-4 | C9H18O2 = 158.2 | 20mg | QQ客服:2056216494 |
| 9-甲氧基-alpha-拉帕醌; 9-Methoxy-alpha-lapachone | CFN98463 | 35241-80-6 | C16H16O4 = 272.3 | 5mg | QQ客服:2056216494 |
| 阿比西尼亚桐素II; Erythrabyssin II | CFN97959 | 77263-06-0 | C25H28O4 = 392.5 | 5mg | QQ客服:2159513211 |
| 等效-14,15-二去甲-13-氧代赖百当-8(17),11-二烯-18-酸; ent-14,15-Dinor-13-oxolabda-8(17),11-dien-18-oic acid | CFN97440 | 875585-30-1 | C18H26O3 = 290.4 | 5mg | QQ客服:1457312923 |